RnRMarketResearch adds ‘Brain Ischemia – Pipeline Review, H1 2015’ to its store. This report provides comprehensive information on the therapeutic development for Brain Ischemia, complete with comparative analysis at various stages.

1. Browse more reports on Neurology Therapeutics at
http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-
therapeutics .
Brain Ischemia Pipeline Review and Drug Analysis Report,
H1 2015
By RnRMarketResearch
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Publisher Name : Global Markets Direct
Date: 29-Apr-2015
No. of pages: 67
Single User License: US $2000

2. Global Markets Direct’s, ‘Brain Ischemia – Pipeline Review, H1 2015′,
provides an overview of the Brain Ischemia’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic
development for Brain Ischemia, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type, along with
latest updates, and featured news and press releases. It also reviews key
players involved in the therapeutic development for Brain Ischemia and
special features on late-stage and discontinued projects.
Brain Ischemia Pipeline Review and Drug
Analysis Report, H1 2015
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441

3. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Brain Ischemia Pipeline Review and Drug
Analysis Report, H1 2015
The report is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put
together by Global Markets Direct’s team. Drug profiles/records featured in
the report undergoes periodic updation following a stringent set of
processes that ensures that all the profiles are updated with the latest set
of information. Additionally, processes including live news & deals tracking,
browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.

4. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Scope:
• The report provides a snapshot of the global therapeutic
landscape of Brain Ischemia
• The report reviews key pipeline products under drug profile
section which includes, product description, MoA and R&D brief,
licensing and collaboration details & other developmental
activities
• The report reviews key players involved in the therapeutics
development for Brain Ischemia and enlists all their major and
minor projects
• The report summarizes all the dormant and discontinued pipeline
projects
Brain Ischemia Pipeline Review and Drug
Analysis Report, H1 2015

5. © http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Reasons to Buy:
• Provides strategically significant competitor information,
analysis, and insights to formulate effective R&D development
strategies
• Identify emerging players with potentially strong product
portfolio and create effective counter-strategies to gain
competitive advantage
• Develop strategic initiatives by understanding the focus areas of
leading companies
• Identify and understand important and diverse types of
therapeutics under development for Brain Ischemia
Brain Ischemia Pipeline Review and Drug
Analysis Report, H1 2015

6. For more details contact Mr. Ritesh Tiwari : sales@rnrmarketresearch.com / +18883915441
RnRMarkertResearch
RnRMarketResearch.com, an online repository of market research reports, offers in-depth
analysis of over 5000 market segments. RnR Market Research library has syndicated reports by
leading market research publishers across the globe.
© http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com
+1 888 391 5441
Brain Ischemia Pipeline Review and Drug
Analysis Report, H1 2015